Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jo A Van Ginderachter

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Vrije Universiteit Brussel

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vrije Universiteit Brussel

Belgium

Head of Lab :: Cellular and Molecular Immunology

Education History

Vrije Universiteit Brussel

Belgium

PHD :: Cellular and Molecular Immunology

Publications

Tessa De Pauw, Lynn De Mey, Debacker Jens, Geert Raes, Jo A Van Ginderachter, Timo W M De Groof, Nick Devoogdt
Current status and future expectations of nanobodies in oncology trials. Expert opinion on investigational drugs (2023)
Romina Mora Barthelmess, Benoît Stijlemans, Jo A Van Ginderachter
Hallmarks of Cancer Affected by the MIF Cytokine Family. Cancers 15 (2) (2023)
Maida Živalj, Jo A Van Ginderachter, Benoît Stijlemans
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy. Cancers 15 (21) (2023)
Romina Mora Barthelmess, Benoît Stijlemans, Jo A Van Ginderachter
Hallmarks of Cancer Affected by the MIF Cytokine Family. Cancers 15 (2) (2023)
Romina Mora Barthelmess, Benoît Stijlemans, Jo A Van Ginderachter
Hallmarks of Cancer Affected by the MIF Cytokine Family. Cancers 15 (2) (2023)
Jo A Van Ginderachter
The Heat Is On: 20-HETE Instructs an Immunosuppressive Phenotype in Cancer-Associated Fibroblasts. Cancer research 82 (21) (2022)
Isaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, Jenny Sprooten, Stefan Naulaerts, Daniel M Borras, Damya Laoui, Massimiliano Mazzone, Jo A Van Ginderachter, Abhishek Dinkarnath Garg
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells 11 (23) (2022)
Isaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, Jenny Sprooten, Stefan Naulaerts, Daniel M Borras, Damya Laoui, Massimiliano Mazzone, Jo A Van Ginderachter, Abhishek Dinkarnath Garg
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells 11 (23) (2022)
Isaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, Jenny Sprooten, Stefan Naulaerts, Daniel M Borras, Damya Laoui, Massimiliano Mazzone, Jo A Van Ginderachter, Abhishek Dinkarnath Garg
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells 11 (23) (2022)
Isaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, Jenny Sprooten, Stefan Naulaerts, Daniel M Borras, Damya Laoui, Massimiliano Mazzone, Jo A Van Ginderachter, Abhishek Dinkarnath Garg
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells 11 (23) (2022)
Evangelia Bolli, Maximilian Scherger, Sana M Arnouk, Ana Rita Pombo Antunes, David Straßburger, Moritz Urschbach, Judith Stickdorn, Karen De Vlaminck, Kiavash Movahedi, Hans Joachim Räder, Sophie Hernot, Pol Besenius, Jo A Van Ginderachter, Lutz Nuhn
Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked Nanobodies. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (10) (2021)
Federico Virga, Federica Cappellesso, Benoît Stijlemans, Anne-Theres Henze, Rosa Trotta, Jonas R M Van Audenaerde, Ananda S Mirchandani, Manuel A Sanchez-Garcia, Jolien Vandewalle, Francesca Orso, Carla Riera-Domingo, Alberto Griffa, Cristina Ivan, Evelien L J Smits, Damya Laoui, Fabio Martelli, Lies Langouche, Greet Van den Berghe, Olivier Feron, Bart Ghesquiere, Hans Prenen, Claude Libert, Sarah R Walmsley, Cyril Corbet, Jo A Van Ginderachter, Mircea Ivan, Daniela Taverna, Massimiliano Mazzone
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation. Science advances 7 (19) (2021)
Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, Maarten Dewilde, Sabrina Rizzolio, Quentin Lecocq, Evangelia Bolli, Ana Rita Santos, Damya Laoui, Steve Schoonooghe, Luca Tamagnone, Cleo Goyvaerts, Massimiliano Mazzone, Karine Breckpot, Jo A Van Ginderachter
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development. Cancers 12 (12) (2020)
Josep Maria Carbó, Theresa E León, Joan Font-Díaz, Juan Vladimir De la Rosa, Antonio Castrillo, Felix S R Picard, Daniel Staudenraus, Magdalena Huber, Lídia Cedó, Joan Carles Escolà-Gil, Lucía Campos, Latifa Bakiri, Erwin F Wagner, Carme Caelles, Thomas Stratmann, Jo A Van Ginderachter, Annabel F Valledor
Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment. Cancer research 81 (4) (2020)
Máté Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, Jiri Keirsse, Pauline M R Bardet, Sana M Arnouk, Yvon Elkrim, Maryse Schmoetten, Jan Brughmans, Ayla Debraekeleer, Amelie Fossoul, Louis Boon, Geert Raes, Geert van Loo, Diether Lambrechts, Massimiliano Mazzone, Alain Beschin, Andy Wullaert, Mohamed Lamkanfi, Jo A Van Ginderachter, Damya Laoui
IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D. Cancer immunology research 9 (3) (2020)
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, Bart Neyns, Kiavash Movahedi, Jo A Van Ginderachter
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies. eLife 9 (2020)
Maximilian Scherger, Evangelia Bolli, Ana Rita Pombo Antunes, Sana Arnouk, Judith Stickdorn, Alexandra Van Driessche, Hansjörg Schild, Stephan Grabbe, Bruno G De Geest, Jo A Van Ginderachter, Lutz Nuhn
Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels. Cells 9 (10) (2020)

Jo A Van Ginderachter.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jo A Van Ginderachter